Megan Levings, Associate Professor in the Department of Surgery, is co-leading a clinical trial that aims to improve long-term survival and quality of life for transplant patients. Working with Denis-Claude Roy of the University of Montreal, they will take a technology developed to improve stem cell transplantation and apply it to kidney transplants, with the goal of reducing the need for immune-suppressant drugs.
The trials are part of the new Canadian National Transplant Research Program, which is also supporting another B.C.-led project, directed by Kirk Schultz, professor in the Division of Hematology and Oncology in the Department of Pediatrics. Schultz’s team will create a national platform to support clinical trials, a national transplant registry effort and a national effort to link biological samples with patient outcomes. For more information, click here.
